Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9.

Pharmacogenetics - 1 Feb 1994

Rettie A E, Wienkers L C, Gonzalez F J, Trager W F, Korzekwa K R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C9
Share to Cytochrome P-450 Enzyme System
Share to Recombinant Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Stereoisomerism

Share to Steroid 16-alpha-Hydroxylase

Share to Tumor Cells, Cultured

Share to Warfarin

Source

Identifiers

PMID: 8004131
DOI: 10.1097/00008571-199402000-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9.PMID 8004131Read ↗

Implications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing.Semantic proximity Read ↗

A novel CYP2C9 variant that caused erroneous genotyping in a patient on warfarin therapy.Semantic proximity Read ↗

A rare G2061 insertion affecting the open reading frame of CYP2D6 and responsible for the poor metabolizer phenotype.Semantic proximity Read ↗

A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) in a patient on warfarin therapy.Semantic proximity Read ↗

Cytochrome P4502C9: an enzyme of major importance in human drug metabolismSemantic proximity Read ↗

Insights into the Genetic Variations of Human Cytochrome P450 2C9: Structural Analysis, Characterization and Comparison.Semantic proximity Read ↗

Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174.Semantic proximity Read ↗

Severely diminished response to vitamin K-treatment for self-inflicted warfarin intoxication in a patient genotyped as CYP2C9*3*3.Semantic proximity Read ↗

CYP2C9 Genotype-Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites.Semantic proximity Read ↗

Warfarin therapy in a patient homozygous for the CYP2C9 3 allele.Semantic proximity Read ↗

Decreased warfarin clearance associated with the CYP2C9 R150H (*8) polymorphism.Semantic proximity Read ↗

Structural Basis of Single-Nucleotide Polymorphisms in Cytochrome P450 2C9.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.